A new study suggests that the immune checkpoint inhibitor, durvalumab, may offer new treatment options for patients living ...
Zanidatamab shows promise in extending survival for patients with HER2-positive biliary tract cancer, marking a significant ...
Everyday Health on MSN
The surprising potential of Ozempic and other GLP-1 drugs for type 1 diabetes
GLP-1 drugs like Ozempic and Mounjaro have significant health benefits for type 1 diabetes, including weight loss, despite ...
About one in nine adults suffer from chronic insomnia and its residual effects like drowsiness, cognitive issues, and ...
According to the World Health Organization, each year cervical cancer impacts approximately 600,000 women throughout the ...
Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013, calling it the biggest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results